344951-08-2

Basic information

• Product Name: Aziridine, 1-[(2-nitrophenyl)sulfonyl]-
• CAS NO: 344951-08-2
• Molecular Formula: C8H8N2O4S
• Molecular Weight: 228.229
• Mol File: 344951-08-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Aziridine, 1-[(2-nitrophenyl)sulfonyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Aziridine, 1-[(2-nitrophenyl)sulfonyl]-(344951-08-2)
• EPA Substance Registry System: Aziridine, 1-[(2-nitrophenyl)sulfonyl]-(344951-08-2)

Safety Data

• Hazardous Substances Data: 344951-08-2(Hazardous Substances Data)

Upstream product

• 496921-42-7 methanesulfonic acid 2-(2-nitrobenzenesulfonylamino) ethyl ester 
• 18226-11-4 N-(2-hydroxy-ethyl)-2-nitro-benzenesulfonamide 
• 1694-92-4 2-Nitrobenzenesulfonyl chloride 
• 1972-28-7 diethylazodicarboxylate 
• 151-56-4 ethyleneimine 
• 54090-41-4 2-nitro-p-toluenesulfonyl chloride 

Downstream Products

• 1361843-53-9 N-(2-nitrophenyl)sulfonyl-2-(2-(E)-buten-1-yloxy)ethylamine 
• 1361844-09-8 4-[(2-nitrophenyl)sulfonyl]-3-vinylmorpholine 
• 1370451-42-5 1-[2-(2-aminophenylsulfonylamino)ethyl]-4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane 
• 122555-91-3 1,4,7-tris-tert-butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane 
• 1370451-36-7 1-[2-(2-nitrophenylsulfonylamino)ethyl]-4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane 
• 344951-14-0 (7-{(diethoxy-phosphoryl)-[2-(2-nitro-benzenesulfonylamino)-ethyl]-amino}-heptyl)-carbamic acid tert-butyl ester 
• 344951-18-4 [7-(2-bromo-acetylamino)-heptyl]-[2-(2-nitro-benzenesulfonylamino)-ethyl]-phosphoramidic acid diethyl ester 
• 344951-20-8 [4-(2-Nitro-benzenesulfonyl)-6-oxo-1,4,7-triaza-cyclotetradec-1-yl]-phosphonic acid diethyl ester 
• 344951-16-2 (7-amino-heptyl)-[2-(2-nitro-benzenesulfonylamino)-ethyl]-phosphoramidic acid diethyl ester 
• 344951-12-8 {7-[2-(2-nitro-benzenesulfonylamino)-ethylamino]-heptyl}-carbamic acid tert-butyl ester 
• 344951-10-6 N-[2-(7-amino-heptylamino)-ethyl]-2-nitro-benzenesulfonamide 

Relevant articles and documents

Carbazole compounds and therapeutic uses of the compounds

Compounds of the general structural formula (I) and (II) and use of the compounds and salts and hydrates thereof, as therapeutic agents are disclosed. Treatable diseases and conditions include cancers, inflammatory diseases and conditions, and immunodeficiency diseases. (I), (II).

Intramolecular Pd(II)-catalyzed aerobic oxidative amination of alkenes: Synthesis of six-membered N-heterocycles

Use of a base-free Pd(DMSO)2(TFA)2 catalyst system enables the synthesis of six-membered nitrogen heterocycles via a Wacker-type aerobic oxidative cyclization of alkenes bearing tethered sulfonamides. Various heterocycles, including morpholines, piperidines, piperazines, and piperazinones, are accessible by this method.

Chiral peptide nucleic acids with a n-aminoethyl-d-proline backbone

Chiral peptide nucleic acids are provided which hybridise strongly with complementary nucleic acids and have potential as antigene and antisense agents and as tools in molecular biology. The compounds have the formulae: where n is 1 to 200, B is a protect